Biogen sees flat 2024 sales, pick up in Alzheimer's drug demand—BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues — Medtech layoffs continue in 2024--http://bit.ly/w28kSd #earnings #biogen #alzheimers #bristolmyerssquibb #biobucks #molecularglue #layoffs #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Public today: We signed a deal with UNP to push peptide macroycles into the intracellular (oncology) space. Excited to see what comes out of it!

https://www.fiercebiotech.com/biotech/merck-co-signs-220m-macrocyclic-peptide-deal-after-hailing-next-wave-drug-discovery

#science #biotech #pharma #biobucks

Goldman Sachs closes $650M fund aimed at biotechs-- Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments— FDA ends busy year with three drug rejections --http://bit.ly/w28kSd #goldmansachs #biobucks #sirna #nash #fda #funding #pharmanews #biotech #biopharma #biotechnology #cafepharma